Fundraising Foxリベロセラ株式会社
3 known investors
Find your way into リベロセラ株式会社
Sign up to find every way you can get introduced to リベロセラ株式会社
- Your email: who you already know at リベロセラ株式会社, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the リベロセラ株式会社 team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
LiberoThera is a drug discovery company using cell-free membrane protein preparation technology and non-natural amino acid incorporation technology to develop antibody-based therapeutics, including antibodies targeting GPCRs such as anti-CCR8. It operates through research alliances and partnerships in the biopharmaceutical field.
Founders & leadership
Investors · 3
Frequently asked questions
- What does リベロセラ株式会社 do?
- LiberoThera is a drug discovery company using cell-free membrane protein preparation technology and non-natural amino acid incorporation technology to develop antibody-based therapeutics, including antibodies targeting GPCRs such as anti-CCR8. It operates through research alliances and partnerships in the biopharmaceutical field.
- Who are リベロセラ株式会社's investors?
- リベロセラ株式会社's investors include MC Healthcare Ventures, Taiho Ventures, LLC, UTokyo Innovation Platform Co. Ltd..